Mark S. Freedman

‘Time is brain’ also in multiple sclerosis
Mult Scler 2009 15: 1133-1134. [PDF] [References] [Request Permission]  

M. Melanson, P. Miao, D. Eisenstat, Y. Gong, X. Gu, K. Au, W. Zhu, F. Begum, EE Frost, and M. Namaka

Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia
Mult Scler 2009 15: 1135-1145. [Abstract] [PDF] [References] [Request Permission]  

DA Fernandes de Abreu, MC Babron I, C. Rebeix, J. Fontenille, D. Yaouanq, B. Brassat, F. Fontaine, F. Clerget-Darpoux, F. Jehan, and Feron

Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis
Mult Scler 2009 15: 1146-1152. [Abstract] [PDF] [References] [Request Permission]  

R. Fazio, ML Malosio, V. Lampasona, D. De Feo, D. Privitera, F. Marnetto, D. Centonze, A. Ghezzi, G. Comi, R. Furlan, and G. Martino

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients
Mult Scler 2009 15: 1153-1163. [Abstract] [PDF] [References] [Request Permission]  

L. Tiemann, IK Penner, M. Haupts, U. Schlegel, and P. Calabrese

Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns
Mult Scler 2009 15: 1164-1174. [Abstract] [PDF] [References] [Request Permission]  

DS Goodin and D. Bates

Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
Mult Scler 2009 15: 1175-1182. [Abstract] [PDF] [References] [Request Permission]  

LM Metz, D. Li, A. Traboulsee, ML Myles, P. Duquette, J. Godin, M. Constantin, and VW Yong

Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
Mult Scler 2009 15: 1183-1194. [Abstract] [PDF] [References] [Request Permission]  

X. Montalban, J. Sastre-Garriga, M. Tintoré, L. Brieva, FX Aymerich, J. Río, J. Porcel, C. Borràs, C. Nos, and À. Rovira

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Mult Scler 2009 15: 1195-1205. [Abstract] [PDF] [References] [Request Permission]  

Bibiana Bielekova, Nancy Richert, Thomas Howard, Amy N Packer, Gregg Blevins, Joan Ohayon, Henry F McFarland, Claus-Steffen Stürzebecher, and Roland Martin

Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis
Mult Scler 2009 15: 1206-1214. [Abstract] [PDF] [References] [Request Permission]  

F. Hamilton, L. Rochester, L. Paul, D. Rafferty, CP O'Leary, and JJ Evans

Walking and talking: an investigation of cognitive—motor dual tasking in multiple sclerosis
Mult Scler 2009 15: 1215-1227. [Abstract] [PDF] [References] [Request Permission]  

DM Meads, LC Doward, SP McKenna, J. Fisk, J. Twiss, and B. Eckert

The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)
Mult Scler 2009 15: 1228-1238. [Abstract] [PDF] [References] [Request Permission]  

JM Wesson, JA Cooper, LS Jehle, SN Lockhart, K. Draney, and J. Barber

The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire
Mult Scler 2009 15: 1239-1249. [Abstract] [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.